SCCHN
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of XB002 in Subjects With Solid Tumors (JEWEL-101) (NCT04925284) | Exelixis | 2021-06-07 |
| Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma (NCT04107103) | AHS Cancer Control Alberta | 2020-03-19 |
| Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen (NCT03771820) | NanoCarrier Co., Ltd. | 2019-07-01 |
| A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors (NCT02573259) | Pfizer | 2016-02-10 |
| Safety and Efficacy Study of Target Therapy Combined With Radiotherapy to Treat Senile Locally Advanced SCCHN (NCT01393184) | Peking University | 2011-03-01 |
Track SCCHN automatically
Every clearance here is in the API, with alerts when new ones post.